Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
WRB W R Berkley Corp
TTWO Take-Two Interactive Software Inc
VIRI Virios Therapeutics Inc
TFX Teleflex Inc
MSFT Microsoft Corp
ASOMY ASOS PLC
GRBG Green Bridge Industries Inc
WBA Walgreens Boots Alliance Inc
TMAC Music Acquisition Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Postmarket

Last Trade
Delayed
$117.02
0.15 (0.13%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$116.87
Day's Change
0.96 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
117.60
Day's Low
115.60
Volume
(Below Average)
Volume:
4,919,359

10-day average volume:
5,535,494
4,919,359

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.